| Irwin Endelman, MD | |
|
6130 W. Parker Rd, Mob 1 Ste 310, Plano, TX 75093 | |
| (972) 981-7927 | |
| (972) 981-7928 |
| Full Name | Irwin Endelman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 6130 W. Parker Rd, Plano, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083705362 | NPI | - | NPPES |
| 106357003 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | H2358 (Texas) | Primary |
| Entity Name | Medical Clinic Of North Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033167234 PECOS PAC ID: 9830084540 Enrollment ID: O20040430001258 |
News Archive
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
The researchers of the University of Helsinki, Finland, and école Polytechnique Fédérale de Lausanne, Switzerland, have shown that vitamin B3 form nicotinamide riboside can slow down the progression of mitochondrial disease, suggesting its potential as a novel therapy approach to adult-onset mitochondrial muscle diseases.
Leatt Corporation, a global developer, marketer and the distributor of the Leatt-Brace, a neck brace system designed to help prevent potentially devastating injuries to the cervical spine (neck) for helmeted sports, announced today that the Company has sued Atlas Brace Technologies US, LLC for infringement on two of the Company's neck brace patents.
Meridian Bioscience, Inc. was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene Malaria test at the 2016 JIB/ACNBH Conference this summer.
› Verified 6 days ago
| Entity Name | Northern Bay Womens Health Center P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295748168 PECOS PAC ID: 4082683453 Enrollment ID: O20041102000185 |
News Archive
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
The researchers of the University of Helsinki, Finland, and école Polytechnique Fédérale de Lausanne, Switzerland, have shown that vitamin B3 form nicotinamide riboside can slow down the progression of mitochondrial disease, suggesting its potential as a novel therapy approach to adult-onset mitochondrial muscle diseases.
Leatt Corporation, a global developer, marketer and the distributor of the Leatt-Brace, a neck brace system designed to help prevent potentially devastating injuries to the cervical spine (neck) for helmeted sports, announced today that the Company has sued Atlas Brace Technologies US, LLC for infringement on two of the Company's neck brace patents.
Meridian Bioscience, Inc. was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene Malaria test at the 2016 JIB/ACNBH Conference this summer.
› Verified 6 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
The researchers of the University of Helsinki, Finland, and école Polytechnique Fédérale de Lausanne, Switzerland, have shown that vitamin B3 form nicotinamide riboside can slow down the progression of mitochondrial disease, suggesting its potential as a novel therapy approach to adult-onset mitochondrial muscle diseases.
Leatt Corporation, a global developer, marketer and the distributor of the Leatt-Brace, a neck brace system designed to help prevent potentially devastating injuries to the cervical spine (neck) for helmeted sports, announced today that the Company has sued Atlas Brace Technologies US, LLC for infringement on two of the Company's neck brace patents.
Meridian Bioscience, Inc. was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene Malaria test at the 2016 JIB/ACNBH Conference this summer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irwin Endelman, MD Po Box 1969, Coppell, TX 75019-1903 Ph: (972) 981-7927 | Irwin Endelman, MD 6130 W. Parker Rd, Mob 1 Ste 310, Plano, TX 75093 Ph: (972) 981-7927 |
News Archive
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
The researchers of the University of Helsinki, Finland, and école Polytechnique Fédérale de Lausanne, Switzerland, have shown that vitamin B3 form nicotinamide riboside can slow down the progression of mitochondrial disease, suggesting its potential as a novel therapy approach to adult-onset mitochondrial muscle diseases.
Leatt Corporation, a global developer, marketer and the distributor of the Leatt-Brace, a neck brace system designed to help prevent potentially devastating injuries to the cervical spine (neck) for helmeted sports, announced today that the Company has sued Atlas Brace Technologies US, LLC for infringement on two of the Company's neck brace patents.
Meridian Bioscience, Inc. was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene Malaria test at the 2016 JIB/ACNBH Conference this summer.
› Verified 6 days ago
Dr. Christy Washington Walker, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6130 W Parker Rd Ste 204, Plano, TX 75093 Phone: 972-981-7861 Fax: 972-981-7862 | |
Surekha Machupalli, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8901 Independence Pkwy, Plano, TX 75025 Phone: 972-908-2444 | |
Dr. Arlene Esther Garcia-soto, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6957 W Plano Pkwy Ste 2000, Plano, TX 75093 Phone: 214-483-6933 Fax: 214-483-6648 | |
Dr. Katrina H Walsh, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Coit Rd, Suite 402, Plano, TX 75075 Phone: 972-519-1900 Fax: 972-964-5323 | |
Dr. Nora L Hsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 280, Plano, TX 75024 Phone: 972-867-6400 | |
Madhuri Gudipaty, M.D Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1600 Coit Rd, Suite 101, Plano, TX 75075 Phone: 972-867-7500 Fax: 972-578-7550 | |
Carol L. Brown-elliott, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3901 W 15th St, #200, Plano, TX 75075 Phone: 972-519-1328 |